Clinical Trial Update: A Clinical Trial of SIBP-A18 Injection in the Treatment of Advanced Malignant Solid Tumor Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating SIBP-A18 injection in adults with advanced malignant solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SIBP-A18 (SIBP-A18)

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Solid Tumor Malignancy | Phase 1 | Status: RECRUITING